Smit EF - Search Results

1

Quality assurance of thoracic radiotherapy in EORTC 08941: a randomised trial of surgery versus thoracic radiotherapy in patients with stage IIIA non-small-cell lung cancer (NSCLC) after response to induction chemotherapy.

Kramer GW, Legrand CL, van Schil P, Uitterhoeve L, Smit EF, Schramel F, Biesma B, Tjan-Heijnen V, van Zandwijk N, Splinter T, Giaccone G, van Meerbeeck JP; EORTC-Lung Cancer Group. Kramer GW, et al. Among authors: smit ef. Eur J Cancer. 2006 Jul;42(10):1391-8. doi: 10.1016/j.ejca.2006.01.052. Eur J Cancer. 2006. PMID: 16785054 Clinical Trial.

2

A phase II study of high dose epirubicin in unresectable non small cell lung cancer.

Smit EF, Berendsen HH, Piers DA, Smeets J, Riva A, Postmus PE. Smit EF, et al. Br J Cancer. 1992 Mar;65(3):405-8. doi: 10.1038/bjc.1992.82. Br J Cancer. 1992. PMID: 1313691 Free PMC article. Clinical Trial.

3

In vitro response of human small-cell lung-cancer cell lines to chemotherapeutic drugs; no correlation with clinical data.

Smit EF, de Vries EG, Timmer-Bosscha H, de Leij LF, Oosterhuis JW, Scheper RJ, Weening JJ, Postmus PE, Mulder NH. Smit EF, et al. Int J Cancer. 1992 Apr 22;51(1):72-8. doi: 10.1002/ijc.2910510115. Int J Cancer. 1992. PMID: 1314232

4

Phase II study of high-dose epirubicin and etoposide in advanced non-small cell lung cancer.

Smit EF, Piers DA, Postmus PE. Smit EF, et al. Eur J Cancer. 1992;28A(12):1965-7. doi: 10.1016/0959-8049(92)90238-w. Eur J Cancer. 1992. PMID: 1329882 Clinical Trial.

5

A phase I study of daily oral teniposide for 20 days.

Smit EF, Splinter TA, Kok TC. Smit EF, et al. Semin Oncol. 1992 Apr;19(2 Suppl 6):40-2. Semin Oncol. 1992. PMID: 1411637

6

A feasibility study of testing new drugs for small-cell lung cancer in patients with a poor performance status.

Postmus PE, Smit EF, Berendsen HH, Sleyfer DT. Postmus PE, et al. Among authors: smit ef. Cancer Chemother Pharmacol. 1991;27(6):490-1. doi: 10.1007/BF00685167. Cancer Chemother Pharmacol. 1991. PMID: 1849466

7

Oral therapy for small cell lung cancer.

Postmus PE, Smit EF. Postmus PE, et al. Among authors: smit ef. Lung Cancer. 1995 Jun;12 Suppl 3:S63-70. doi: 10.1016/s0169-5002(10)80019-4. Lung Cancer. 1995. PMID: 7551958 Review.

8

Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancer.

Groen HJ, Smit EF, Haaxma-Reiche H, Postmus PE. Groen HJ, et al. Among authors: smit ef. Eur J Cancer. 1993;29A(12):1696-9. doi: 10.1016/0959-8049(93)90107-q. Eur J Cancer. 1993. PMID: 7691116

9

Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.

Postmus PE, Smit EF, Haaxma-Reiche H, van Zandwijk N, Ardizzoni A, Quoix E, Kirkpatrick A, Sahmoud T, Giaccone G. Postmus PE, et al. Among authors: smit ef. J Clin Oncol. 1995 Mar;13(3):660-5. doi: 10.1200/JCO.1995.13.3.660. J Clin Oncol. 1995. PMID: 7884426 Clinical Trial.

10

Testing the possible non-cross resistance of two equipotent combination chemotherapy regimens against small-cell lung cancer: a phase II study of the EORTC Lung Cancer Cooperative Group.

Postmus PE, Smit EF, Kirkpatrick A, Splinter TA. Postmus PE, et al. Among authors: smit ef. Eur J Cancer. 1993;29A(2):204-7. doi: 10.1016/0959-8049(93)90176-g. Eur J Cancer. 1993. PMID: 8380697 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

529 results

Search Page

Filters